Scaling the Andean Shilajit: A Novel Neuroprotective Agent for Alzheimer's Disease

• Egile Nagusiak: Víctor Andrade (Egilea), Maylin Wong-Guerra (Egilea), Nicole Cortés (Egilea), Gabriela Pastor (Egilea), Andrea González (Egilea), Camila Calfío (Egilea), Leonardo Guzmán-Martínez (Egilea), Leonardo P. Navarrete (Egilea), Nicolas Ramos-Escobar (Egilea), Inelia Morales (Egilea), Rocío Santander (Egilea), Juan Andrades-Lagos (Egilea), Mitchell Bacho (Egilea), Leonel E. Rojo (Egilea), Ricardo Benjamín Maccioni (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2023-07-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

Alzheimer's disease (AD) is a multifactorial neurodegenerative disorder without a cure, despite the enormous number of investigations and therapeutic approaches. AD is a consequence of microglial responses to "damage signals", such as aggregated tau oligomers, which trigger a neuro-in...